Therapeutic drug monitoring is necessary for patients receiving posaconazole tablet

J Infect. 2021 Jun;82(6):e18-e21. doi: 10.1016/j.jinf.2021.03.021. Epub 2021 Mar 29.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Antifungal Agents / therapeutic use
  • Drug Monitoring*
  • Humans
  • Tablets
  • Triazoles*

Substances

  • Antifungal Agents
  • Tablets
  • Triazoles
  • posaconazole